Article

Apnea Patients Should Keep an Eye Out for Glaucoma

Author(s):

Successfully measuring the eye pressure of people with obstructive sleep apnea (OSA) indicated to scientists for the first time a relationship between sleep apnea and glaucoma.

Successfully measuring the eye pressure of people with obstructive sleep apnea (OSA) indicated to scientists for the first time a relationship between sleep apnea and glaucoma.

Specifically, research from Hokkaido University showed that OSA patients were nearly 10 times more likely than non-OSA patients to suffer from glaucoma — optic nerve disease triggered from increased eye pressure.

To effectively measure eye pressure in sleeping subjects, the research team used a special sensor similar to a contact lens to assess the pressure changes when OSA patients’ breathing stopped during sleep.

Typically, intrathoracic pressure rises if people stop breathing/exhaling, leading to higher eye pressure.

However, during their research, the team unexpectedly found that the eye pressure dropped when study participants stopped breathing. These patients also were likely to stop inhaling, not exhaling, as a result of closed airways, triggering lower intrathoracic pressure.

Additionally, the team noted the patients exhibited hypoxic effects, potentially causing optic nerve damage leading to glaucoma.

The authors concluded that the optic nerve could be damaged as a result of hypoxia without an increase in eye pressure — information that can help dissect the symptoms experienced by glaucoma patients with normal eye pressure levels.

Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
© 2024 MJH Life Sciences

All rights reserved.